845 related articles for article (PubMed ID: 32067535)
1. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study.
Vermeulen BD; Bruggeman L; Bac DJ; Schrauwen RWM; Epping LSM; Scheffer RCH; Tan ACITL; Groenen MJM; Verhoeven RHA; Siersema PD
Acta Oncol; 2020 Apr; 59(4):410-416. PubMed ID: 32067535
[No Abstract] [Full Text] [Related]
2. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
Opstelten JL; de Wijkerslooth LR; Leenders M; Bac DJ; Brink MA; Loffeld BC; Meijnen-Bult MJ; Minderhoud IM; Verhagen MA; van Oijen MG; Siersema PD
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26919349
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach.
Cellini F; Morganti AG; Di Matteo FM; Mattiucci GC; Valentini V
Radiat Oncol; 2014 Feb; 9():45. PubMed ID: 24499595
[TBL] [Abstract][Full Text] [Related]
4. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
[TBL] [Abstract][Full Text] [Related]
5. Time to adjuvant therapy and other variables in localized gastric and gastroesophageal junction (GEJ) cancer (IJGC-D-13-00162).
Ahmed S; Iqbal N; Yadav S; Zaidi A; Ahmed O; Alvi R; Gardner D; Haider K
J Gastrointest Cancer; 2014 Sep; 45(3):284-90. PubMed ID: 24493115
[TBL] [Abstract][Full Text] [Related]
6. Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden.
Linder G; Sandin F; Johansson J; Lindblad M; Lundell L; Hedberg J
Cancer Epidemiol; 2018 Feb; 52():91-98. PubMed ID: 29278841
[TBL] [Abstract][Full Text] [Related]
7. 101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.
Mizrak Kaya D; Wang X; Harada K; Blum Murphy MA; Das P; Minsky BD; Estrella JS; Lin Q; Amlashi FG; Lee JH; Weston B; Bhutani MS; Matamoros A; Sagebiel T; Wu CC; Rogers JE; Thomas I; Maru DM; Skinner HD; Badgwell BD; Hofstetter WL; Ajani JA
Oncology; 2017; 93(4):243-248. PubMed ID: 28683449
[TBL] [Abstract][Full Text] [Related]
8. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer.
Davies AR; Deans DA; Penman I; Plevris JN; Fletcher J; Wall L; Phillips H; Gilmour H; Patel D; de Beaux A; Paterson-Brown S
Dis Esophagus; 2006; 19(6):496-503. PubMed ID: 17069595
[TBL] [Abstract][Full Text] [Related]
9. Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study.
van Hagen P; Spaander MC; van der Gaast A; van Rij CM; Tilanus HW; van Lanschot JJ; Wijnhoven BP;
Int J Clin Oncol; 2013 Apr; 18(2):214-9. PubMed ID: 22193638
[TBL] [Abstract][Full Text] [Related]
10. Current state of surgical treatment of cancer of the stomach and gastro-esophageal junction in the Czech Republic.
Duda M; Dušek L; Jínek T; Adamčík L; Škrovina M
Rozhl Chir; 2018; 97(7):309-319. PubMed ID: 30442012
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness in esophagogastric cancer.
Knab LM; Belotte J; Munshi HG; Bentrem DJ
Cancer Treat Res; 2015; 164():121-42. PubMed ID: 25677022
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for Esophageal Adenocarcinoma.
Lam KO; Kwong DLW
Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
[TBL] [Abstract][Full Text] [Related]
13. Patient, nursing and medical staff experiences and perceptions of the care of people with palliative esophagogastric cancer: a systematic review of the qualitative evidence.
Cowley A; Evans C; Bath-Hextall F; Cooper J
JBI Database System Rev Implement Rep; 2016 Oct; 14(10):134-166. PubMed ID: 27846123
[TBL] [Abstract][Full Text] [Related]
14. [CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS].
Bišof V; Juretić A; Stančić-Rokotov D; Rustemović N; Miletić D; Boban M; Omrčen T; Razumović JJ; Pavlović I; Fröbe A; Čonkaš M; Rakušić Z; Gugić D
Lijec Vjesn; 2016; 138(9-10):233-9. PubMed ID: 30148543
[TBL] [Abstract][Full Text] [Related]
15. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
[TBL] [Abstract][Full Text] [Related]
16. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.
Wagner AD; Lordick F; Grabsch HI; Terashima M; Terada M; Yoshikawa T; Boku N; Kataoka K; Smyth EC; Mauer M; Haustermans K; Moehler MH
Eur J Cancer; 2020 Jan; 124():67-76. PubMed ID: 31759294
[TBL] [Abstract][Full Text] [Related]
18. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
[TBL] [Abstract][Full Text] [Related]
19. Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer.
Hingorani M; Dixit S; Johnson M; Plested V; Alty K; Colley P; Beavis AW; Roy R; Maraveyas A
Cancer Res Treat; 2015 Oct; 47(4):706-17. PubMed ID: 25687854
[TBL] [Abstract][Full Text] [Related]
20. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
